Logistical, technical, and radiation safety aspects of establishing a radiopharmaceutical therapy program: A case in Lutetium-177 prostate-specific membrane antigen (PSMA) therapy.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of applied clinical medical physics"
DOI: 10.1002/acm2.13899
Abstract: Prostate-specific membrane antigen (PSMA) is a cell surface protein highly expressed in nearly all prostate cancers, with restricted expression in some normal tissues. The differential expression of PSMA from tumor to non-tumor tissue has resulted… read more here.
Keywords: prostate specific; radiopharmaceutical therapy; therapy; program ... See more keywords
Novel theranostic agent for PET imaging and targeted radiopharmaceutical therapy of tumour-infiltrating immune cells in glioma
Sign Up to like & getrecommendations! Published in 2021 at "EBioMedicine"
DOI: 10.1016/j.ebiom.2021.103571
Abstract: Background Malignant gliomas are deadly tumours with few therapeutic options. Although immunotherapy may be a promising therapeutic strategy for treating gliomas, a significant barrier is the CD11b+ tumour-associated myeloid cells (TAMCs), a heterogeneous glioma infiltrate… read more here.
Keywords: radiopharmaceutical therapy; targeted radiopharmaceutical; tumour; lumi804 cd11b ... See more keywords
Dosimetry, Radiobiology and Synthetic Lethality: Radiopharmaceutical Therapy (RPT) With Alpha-Particle-Emitters.
Sign Up to like & getrecommendations! Published in 2020 at "Seminars in nuclear medicine"
DOI: 10.1053/j.semnuclmed.2019.11.002
Abstract: As a treatment modality that is fundamentally different from other therapies against cancer, radiopharmaceutical therapy with alpha-particle emitters has drawn the attention of the therapy community and also the biopharmaceutical industry. Alpha-particles cause a preponderance… read more here.
Keywords: particle emitters; alpha particle; radiobiology; therapy ... See more keywords